LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 3 of total 3

Search options

  1. Article ; Online: SARS-CoV-2, COVID-19, skin and immunology - What do we know so far?

    Novak, Natalijia / Peng, Wenming / Naegeli, Mirjam C / Galvan, Christina / Kolm-Djamei, Isabel / Brüggen, Charlotte / Cabanillas, Beatriz / Schmid-Grendelmeier, Peter / Catala, Alba

    Allergy

    2020  Volume 76, Issue 3, Page(s) 698–713

    Abstract: The pandemic condition coronavirus disease (COVID-19), caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), can take asymptomatic, mild, moderate, and severe courses. COVID-19 affects primarily the respiratory airways leading ...

    Abstract The pandemic condition coronavirus disease (COVID-19), caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), can take asymptomatic, mild, moderate, and severe courses. COVID-19 affects primarily the respiratory airways leading to dry cough, fever, myalgia, headache, fatigue, and diarrhea and can end up in interstitial pneumonia and severe respiratory failure. Reports about the manifestation of various skin lesions and lesions of the vascular system in some subgroups of SARS-CoV-2-positive patients as such features outside the respiratory sphere, are rapidly emerging. Vesicular, urticarial, and maculopapular eruptions and livedo, necrosis, and other vasculitis forms have been reported most frequently in association with SARS-CoV-2 infection. In order to update information gained, we provide a systematic overview of the skin lesions described in COVID-19 patients, discuss potential causative factors, and describe differential diagnostic evaluations. Moreover, we summarize current knowledge about immunologic, clinical, and histologic features of virus- and drug-induced lesions of the skin and changes to the vascular system in order to transfer this knowledge to potential mechanisms induced by SARS-CoV-2.
    MeSH term(s) Angiotensin-Converting Enzyme 2/analysis ; COVID-19/complications ; COVID-19/immunology ; COVID-19/pathology ; COVID-19/transmission ; Female ; Humans ; Male ; SARS-CoV-2 ; Skin/pathology ; Skin Diseases/etiology ; Skin Diseases/pathology
    Chemical Substances ACE2 protein, human (EC 3.4.17.23) ; Angiotensin-Converting Enzyme 2 (EC 3.4.17.23)
    Keywords covid19
    Language English
    Publishing date 2020-08-12
    Publishing country Denmark
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Review
    ZDB-ID 391933-x
    ISSN 1398-9995 ; 0105-4538
    ISSN (online) 1398-9995
    ISSN 0105-4538
    DOI 10.1111/all.14498
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: SARS‐CoV‐2, COVID‐19, skin and immunology – What do we know so far?

    Novak, Natalijia / Peng, Wenming / Naegeli, Mirjam C. / Galvan, Christina / Kolm‐Djamei, Isabel / Brüggen, Charlotte / Cabanillas, Beatriz / Schmid‐Grendelmeier, Peter / Catala, Alba

    Allergy ; ISSN 0105-4538 1398-9995

    2020  

    Keywords Immunology ; Immunology and Allergy ; covid19
    Language English
    Publisher Wiley
    Publishing country us
    Document type Article ; Online
    DOI 10.1111/all.14498
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  3. Article: SARS-CoV-2, COVID-19, skin and immunology - What do we know so far?

    Novak, Natalijia / Peng, Wenming / Naegeli, Mirjam C / Galvan, Christina / Kolm-Djamei, Isabel / Brüggen, Charlotte / Cabanillas, Beatriz / Schmid-Grendelmeier, Peter / Catala, Alba

    Allergy

    Abstract: The pandemic condition coronavirus disease (COVID-19), caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), can take asymptomatic, mild, moderate, and severe courses. COVID-19 affects primarily the respiratory airways leading ...

    Abstract The pandemic condition coronavirus disease (COVID-19), caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), can take asymptomatic, mild, moderate, and severe courses. COVID-19 affects primarily the respiratory airways leading to dry cough, fever, myalgia, headache, fatigue, and diarrhea and can end up in interstitial pneumonia and severe respiratory failure. Reports about the manifestation of various skin lesions and lesions of the vascular system in some subgroups of SARS-CoV-2-positive patients as such features outside the respiratory sphere, are rapidly emerging. Vesicular, urticarial, and maculopapular eruptions and livedo, necrosis, and other vasculitis forms have been reported most frequently in association with SARS-CoV-2 infection. In order to update information gained, we provide a systematic overview of the skin lesions described in COVID-19 patients, discuss potential causative factors, and describe differential diagnostic evaluations. Moreover, we summarize current knowledge about immunologic, clinical, and histologic features of virus- and drug-induced lesions of the skin and changes to the vascular system in order to transfer this knowledge to potential mechanisms induced by SARS-CoV-2.
    Keywords covid19
    Publisher WHO
    Document type Article
    Note WHO #Covidence: #641232
    Database COVID19

    Kategorien

To top